Almenoff June Sherie
SEC Form 4 insider trading activity
Almenoff June Sherie has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including ATNM, TENX, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Almenoff June Sherie is listed as Director at TENAX THERAPEUTICS, INC. Inside the rolling window, Almenoff June Sherie reported 2 open-market purchases totaling $15K in TENX and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,900 TENX shares on Nov 18, 2025, worth $14K.
Companies traded
Other insiders at ATNM
Insider Buying
$15K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Almenoff June Sherie made?
Almenoff June Sherie has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including ATNM, TENX since 2025.
Which companies does Almenoff June Sherie trade?
Almenoff June Sherie has filed SEC Form 4 disclosures for 2 companies, including ATNM, TENX.
When was Almenoff June Sherie's most recent SEC Form 4 filing?
Almenoff June Sherie's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Almenoff June Sherie's total buy and sell value in the current window?
Inside the rolling retention window, Almenoff June Sherie bought $15K and sold $0 based on SEC Form 4 filings.
What was Almenoff June Sherie's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,900 TENX shares on 2025-11-18, worth $14K, per SEC Form 4 filings.